This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Influenza, Human
and you are
between 19 and 49
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

The purpose of this study is to evaluate FluMist with and without Ampligen in healthy volunteers.

Provided treatments

  • Drug: Poly I:Poly C12U 50 ug
  • Drug: Poly I:Poly C12U 200 ug
  • Drug: Poly I:Poly C12U 500 ug
  • Drug: Poly I:Poly C12U 1250 ug
  • Drug: Placebo
  • Drug: FluMist

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01591473. The sponsor of the trial is AIM ImmunoTech Inc. and it is looking for 55 volunteers for the current phase.
Official trial title:
A Phase I/II, Two-Staged, Single-Center, Randomized, Double-Blind, Antibody Titer Study to Assess Immunogenicity and Safety of FluMist® Intranasal Influenza Vaccine Administered With and Without a TLR-3 Agonist, Ampligen®.